TF and renal cell carcinoma: To investigate the downstream effects of TF binding disruption at RCC-associated GWAS loci, we integrated plasma proteomic data from the UK Biobank Pharma Proteomics Project (UKB-PPP)38, encompassing 2,940 proteins from 34,557 individuals of European ancestry.